Mara R Goetz
Overview
Explore the profile of Mara R Goetz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
15
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ritter A, Welsch T, Brodersen F, Auinger J, Moll-Khosrawi P, Goetz M, et al.
Ann Surg Open
. 2024 Dec;
5(4):e501.
PMID: 39711657
Objective: The aim was to evaluate the sustainability of the pancreatic Enhanced Recovery After Surgery (ERAS) program and the effect of ERAS items on patient morbidity and hospital stay. Background:...
2.
Andel P, van Goor I, Augustinus S, Berrevoet F, Besselink M, Bhojwani R, et al.
JAMA Surg
. 2024 Nov;
160(1):74-84.
PMID: 39504033
Importance: International guidelines lack consistency in their recommendations regarding routine imaging in the follow-up after pancreatic resection for pancreatic ductal adenocarcinoma (PDAC). Consequently, follow-up strategies differ between centers worldwide. Objective:...
3.
Willner A, Radulova-Mauersberger O, Barenbrock A, Distler M, Korn S, Jimenez R, et al.
BJS Open
. 2024 Oct;
8(5).
PMID: 39436640
No abstract available.
4.
Galvez-Montosa F, Peduzzi G, Sanchez-Maldonado J, Ter Horst R, Cabrera-Serrano A, Gentiluomo M, et al.
Int J Cancer
. 2024 Sep;
156(2):339-352.
PMID: 39319538
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers with patients having unresectable or metastatic disease at diagnosis, with poor prognosis and very short survival. Given that genetic...
5.
Goetz M, Heumann A, Bassi C, Landoni L, Khatib-Chahidi K, Ghadimi M, et al.
HPB (Oxford)
. 2024 Apr;
26(7):903-910.
PMID: 38653711
Objective: The incidence for clinically relevant postoperative pancreatic fistulas (CR-POPF) in distal pancreatectomy (DP) ranges up to 25%. None of the available sealants significantly reduce CR-POPF. A new biodegradable sealant...
6.
Stern L, Schuette M, Goetz M, Nitschke C, Bardenhagen J, Scognamiglio P, et al.
HPB (Oxford)
. 2023 Sep;
26(1):117-124.
PMID: 37770362
Background: Despite exocrine pancreatic insufficiency (EPI) being a significant consequence of pancreatic surgery, there is still no consensus on its perioperative management. This study aimed to evaluate unselective pancreatic enzyme...
7.
Nitschke C, Markmann B, Walter P, Badbaran A, Tolle M, Kropidlowski J, et al.
Clin Chem
. 2023 Jan;
69(3):295-307.
PMID: 36644936
Background: KRAS circulating tumor DNA (ctDNA) has shown biomarker potential for pancreatic ductal adenocarcinoma (PDAC) but has not been applied in clinical routine yet. We aim to improve clinical applicability...
8.
Nitschke C, Markmann B, Tolle M, Kropidlowski J, Belloum Y, Goetz M, et al.
Cancers (Basel)
. 2022 Sep;
14(18).
PMID: 36139565
Background: In pancreatic ductal adenocarcinoma (PDAC), the characterization of circulating tumor cells (CTCs) opens new insights into cancer metastasis as the leading cause of cancer-related death. Here, we focused on...
9.
Bahar A, Goetz M, Uzunoglu F, Gungor C, Reeh M, Izbicki J, et al.
HPB (Oxford)
. 2021 Dec;
24(5):624-634.
PMID: 34922845
Background: To date, no approved sealants for the prevention of postoperative pancreatic fistulas (POPFs) or bile leakage are available. The aim of the study is to assess the feasibility of...